Therapy News and Research

RSS

FDA advisory committee recommends that FDA wait for overall survival results from Satraplatin phase 3 trial

GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.

25 Jul 2007

New findings on vitamin D

Surprising findings by Queen's University researchers have shed new light on how the 'sunshine vitamin' - D - increasingly used to treat and prevent cancer and other diseases is broken down by our bodies.

25 Jul 2007

CTRC enrolls first patients in study for sarcoma

The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung.

25 Jul 2007

Breast cancer and HRT

The medical community has been debating for many years whether, and to what extent, postmenopausal hormone therapy (HT) use is associated with a higher risk of breast cancer, says Professor Amos Pines, President of the International Menopause Society.

25 Jul 2007

Regular mammograms after breast cancer lower rate of death from breast cancer

Older women who get yearly mammograms after treatment of early-stage breast cancer are less likely to die from breast cancer, according to a study in the July 20, 2007 issue of the Journal of Clinical Oncology.

24 Jul 2007

Link between low cholesterol levels and cancer

Millions of Americans take statins to lower their cholesterol, but how low should you go?

24 Jul 2007

NSAIDs can reduce colorectal cancer risk

A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer.

24 Jul 2007

Studies assess blood clot prevalence outside hospital prevention in hospital

More cases of venous thromboembolism are diagnosed in the three months following hospitalization than during hospitalization, but less than half of inpatients receive medications to prevent blood clots from occurring, according to a report in the July 23 issue of Archives of Internal Medicine.

24 Jul 2007

New studies emphasize need for influenza and measles vaccinations in HIV-infected patients

Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals.

24 Jul 2007

New algorithm matches any tumor cells to best possible anti-cancer treatments

Cancer patients don't have time to waste. Many go through several different treatments, however, to find one that is more effective against their particular type of tumor.

24 Jul 2007

Double depression

There's depression, and then there's double depression.

24 Jul 2007

Adult survivors of childhood leukemia exercise less putting themselves at risk for obesity

Overcoming pediatric cancer may only mark the beginning of a young survivor's lifelong battle to stay healthy.

24 Jul 2007

The good news and the bad news on AIDS

In an address by Dr. Anthony Fauci, George Bush's top adviser on HIV/AIDS, delegates were told the world is losing the battle against the virus and though progress had been made, more people were being infected with HIV than were being treated.

23 Jul 2007

Nanoscale dots target and track apoptosis

Apoptosis, or programmed cell death, is a hallmark effect triggered by effective anticancer drugs. Now, researchers in Korea have developed a biocompatible, fluorescent nanoparticle that could provide an early sign that apoptosis is occurring as a result of anticancer therapy.

23 Jul 2007

Experts say world on the brink of beating AIDS

Leading AIDS experts speaking at an international conference in Sydney, Australia say the world is on the brink of beating the deadly virus.

23 Jul 2007

New hope for common form of childhood cancer

Dr. Richard Lock, Head of the Leukaemia Biology Program at the Children's Cancer Institute Australia for Medical Research, Sydney, along with collaborators from the Childrens Hospital Los Angeles and University of Southern California, USA, recently published their findings in the prestigious scientific journal Blood.

23 Jul 2007

Latest drugs improve survival for metastatic breast cancer

Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.

23 Jul 2007

IDM Pharma plans to amend NDA for Mifamurtide (L-MTP-PE) for the treatment of osteosarcoma

IDM Pharma, Inc. has announced that it has recently met with the U.S. Food and Drug Administration (FDA) and informed the FDA that the Company intends to take immediate action to supplement the data in its current New Drug Application (NDA) for mifamurtide (L-MTP-PE), formerly known as Junovan, which is being reviewed for the treatment of children and adolescents with non-metastatic osteosarcoma.

23 Jul 2007

Urgent needs of HIV-positive women discussed

Women Living Positive, a roundtable discussion at the IAS congress in Sydney, featured the perspectives of an international panel, including experts in HIV research and medicine, an HIV-positive woman and a member of Australia's National Association of People Living with HIV/AIDS (NAPWA), on the progress that has been made, and what remains to be done to address the needs of HIV-positive women.

23 Jul 2007

Group therapy does not prolong the lives of women with metastatic breast cancer

Earlier results from the same researcher had suggested a survival benefit of group therapy for women with metastatic breast cancer. However, the new study did find that women with estrogen receptor (ER) negative tumors did show survival benefit, and that group therapy improved quality of life (QOL).

23 Jul 2007